CBT for Insomnia in Cannabis Users
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines the effectiveness of two treatments for individuals who use cannabis and experience sleep difficulties. One group will receive cognitive behavioral therapy specifically for insomnia (CBT for Insomnia), while the other will receive education on good sleep habits. The researchers aim to assess how these treatments impact sleep quality, cannabis use, and daytime functioning. Individuals who frequently struggle with sleep, use cannabis at least three times a week, and have a stable living situation may be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to significant research that could enhance sleep and overall well-being.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those using medications known to have started their insomnia. It's best to discuss your specific medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that Cognitive Behavioral Therapy for insomnia (CBTi) is generally safe. Studies indicate that participants who tried CBTi did not experience major negative effects and developed better attitudes towards sleep, demonstrating that CBTi is well-tolerated. Sleep Hygiene Education, the other treatment in this trial, is also safe. It involves learning good sleep habits and does not cause negative side effects. Both treatments have been used safely in previous studies.12345
Why are researchers excited about this trial?
Researchers are excited about using Cognitive Behavioral Therapy for insomnia (CBTi) among cannabis users because it is delivered via telemedicine, making it highly accessible for individuals who might not have easy access to in-person therapy. Unlike traditional therapy options that often require face-to-face sessions, this method allows participants to receive treatment in the comfort of their own homes. Additionally, CBTi specifically targets the thoughts and behaviors that contribute to insomnia, offering a focused approach that might be more effective for this group than general sleep aids or medications. By combining this with Sleep Hygiene Education, the trial aims to provide comprehensive support, potentially improving sleep quality without relying on drugs.
What evidence suggests that this trial's treatments could be effective for insomnia in cannabis users?
Research has shown that cognitive behavioral therapy for insomnia (CBTi) can assist people who use cannabis. Studies have found that CBTi improves sleep and reduces insomnia severity. It also appears to alleviate anxiety and depression. In this trial, participants will receive either CBTi-CB-TM, a version of CBTi tailored for cannabis users, or Sleep Hygiene Education. CBTi-CB-TM has shown promise in enhancing sleep and decreasing cannabis use. Both therapies are offered through telemedicine, ensuring easy access and convenience.24567
Who Is on the Research Team?
Todd Arnedt, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
Adults with mild insomnia and problematic cannabis use, using cannabis for sleep at least three times a week. Must have stable housing, Wi-Fi access, and be able to visit Ann Arbor for assessments. Excludes non-English speakers, those unable to consent, diagnosed with certain mental disorders or on night shifts.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive telemedicine-delivered cognitive behavioral therapy for insomnia or sleep hygiene education
Follow-up
Participants are monitored for sleep, cannabis use, and daytime functioning
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy for insomnia
- Sleep Hygiene Education
Cognitive Behavioral Therapy for insomnia is already approved in United States, European Union for the following indications:
- Insomnia
- Anxiety
- Depression
- Insomnia
- Anxiety
- Depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator